These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
338 related articles for article (PubMed ID: 22065079)
1. Molecular pathways: targeting mechanisms of asbestos and erionite carcinogenesis in mesothelioma. Carbone M; Yang H Clin Cancer Res; 2012 Feb; 18(3):598-604. PubMed ID: 22065079 [TBL] [Abstract][Full Text] [Related]
2. The role of key genes and pathways involved in the tumorigenesis of Malignant Mesothelioma. de Assis LV; Locatelli J; Isoldi MC Biochim Biophys Acta; 2014 Apr; 1845(2):232-47. PubMed ID: 24491449 [TBL] [Abstract][Full Text] [Related]
3. Asbestos-induced chronic inflammation in malignant pleural mesothelioma and related therapeutic approaches-a narrative review. Zolondick AA; Gaudino G; Xue J; Pass HI; Carbone M; Yang H Precis Cancer Med; 2021 Sep; 4():. PubMed ID: 35098108 [TBL] [Abstract][Full Text] [Related]
4. Molecular pathogenesis of malignant mesothelioma. Sekido Y Carcinogenesis; 2013 Jul; 34(7):1413-9. PubMed ID: 23677068 [TBL] [Abstract][Full Text] [Related]
5. The pathogenesis of mesothelioma. Carbone M; Bedrossian CW Semin Diagn Pathol; 2006 Feb; 23(1):56-60. PubMed ID: 17044196 [TBL] [Abstract][Full Text] [Related]
6. Clinical and prognostic features of erionite-induced malignant mesothelioma. Demirer E; Ghattas CF; Radwan MO; Elamin EM Yonsei Med J; 2015 Mar; 56(2):311-23. PubMed ID: 25683976 [TBL] [Abstract][Full Text] [Related]
8. The pathogenesis of mesothelioma. Carbone M; Kratzke RA; Testa JR Semin Oncol; 2002 Feb; 29(1):2-17. PubMed ID: 11836664 [TBL] [Abstract][Full Text] [Related]
9. Lung diseases due to environmental exposures to erionite and asbestos in Turkey. Emri S; Demir A; Dogan M; Akay H; Bozkurt B; Carbone M; Baris I Toxicol Lett; 2002 Feb; 127(1-3):251-7. PubMed ID: 12052665 [TBL] [Abstract][Full Text] [Related]
10. Tumor suppressor alterations cooperate to drive aggressive mesotheliomas with enriched cancer stem cells via a p53-miR-34a-c-Met axis. Menges CW; Kadariya Y; Altomare D; Talarchek J; Neumann-Domer E; Wu Y; Xiao GH; Shapiro IM; Kolev VN; Pachter JA; Klein-Szanto AJ; Testa JR Cancer Res; 2014 Feb; 74(4):1261-1271. PubMed ID: 24371224 [TBL] [Abstract][Full Text] [Related]
11. A mouse model recapitulating molecular features of human mesothelioma. Altomare DA; Vaslet CA; Skele KL; De Rienzo A; Devarajan K; Jhanwar SC; McClatchey AI; Kane AB; Testa JR Cancer Res; 2005 Sep; 65(18):8090-5. PubMed ID: 16166281 [TBL] [Abstract][Full Text] [Related]
12. Erionite and asbestos differently cause transformation of human mesothelial cells. Bertino P; Marconi A; Palumbo L; Bruni BM; Barbone D; Germano S; Dogan AU; Tassi GF; Porta C; Mutti L; Gaudino G Int J Cancer; 2007 Jul; 121(1):12-20. PubMed ID: 17354240 [TBL] [Abstract][Full Text] [Related]
13. Malignant pleural mesothelioma in Turkey, 2000-2002. Emri S; Demir AU Lung Cancer; 2004 Aug; 45 Suppl 1():S17-20. PubMed ID: 15261427 [TBL] [Abstract][Full Text] [Related]
14. Asbestos induces mesothelial cell transformation via HMGB1-driven autophagy. Xue J; Patergnani S; Giorgi C; Suarez J; Goto K; Bononi A; Tanji M; Novelli F; Pastorino S; Xu R; Caroccia N; Dogan AU; Pass HI; Tognon M; Pinton P; Gaudino G; Mak TW; Carbone M; Yang H Proc Natl Acad Sci U S A; 2020 Oct; 117(41):25543-25552. PubMed ID: 32999071 [TBL] [Abstract][Full Text] [Related]
15. Similar tumor suppressor gene alteration profiles in asbestos-induced murine and human mesothelioma. Lecomte C; Andujar P; Renier A; Kheuang L; Abramowski V; Mellottee L; Fleury-Feith J; Zucman-Rossi J; Giovannini M; Jaurand MC Cell Cycle; 2005 Dec; 4(12):1862-9. PubMed ID: 16319530 [TBL] [Abstract][Full Text] [Related]
16. Long-Fiber Carbon Nanotubes Replicate Asbestos-Induced Mesothelioma with Disruption of the Tumor Suppressor Gene Cdkn2a (Ink4a/Arf). Chernova T; Murphy FA; Galavotti S; Sun XM; Powley IR; Grosso S; Schinwald A; Zacarias-Cabeza J; Dudek KM; Dinsdale D; Le Quesne J; Bennett J; Nakas A; Greaves P; Poland CA; Donaldson K; Bushell M; Willis AE; MacFarlane M Curr Biol; 2017 Nov; 27(21):3302-3314.e6. PubMed ID: 29112861 [TBL] [Abstract][Full Text] [Related]
17. Mesothelioma epidemiology, carcinogenesis, and pathogenesis. Yang H; Testa JR; Carbone M Curr Treat Options Oncol; 2008 Jun; 9(2-3):147-57. PubMed ID: 18709470 [TBL] [Abstract][Full Text] [Related]
18. Inflammation-Related IL1β/IL1R Signaling Promotes the Development of Asbestos-Induced Malignant Mesothelioma. Kadariya Y; Menges CW; Talarchek J; Cai KQ; Klein-Szanto AJ; Pietrofesa RA; Christofidou-Solomidou M; Cheung M; Mossman BT; Shukla A; Testa JR Cancer Prev Res (Phila); 2016 May; 9(5):406-414. PubMed ID: 26935421 [TBL] [Abstract][Full Text] [Related]
19. Activated TNF-alpha/NF-kappaB signaling via down-regulation of Fas-associated factor 1 in asbestos-induced mesotheliomas from Arf knockout mice. Altomare DA; Menges CW; Pei J; Zhang L; Skele-Stump KL; Carbone M; Kane AB; Testa JR Proc Natl Acad Sci U S A; 2009 Mar; 106(9):3420-5. PubMed ID: 19223589 [TBL] [Abstract][Full Text] [Related]
20. HMGB1 released by mesothelial cells drives the development of asbestos-induced mesothelioma. Suarez JS; Novelli F; Goto K; Ehara M; Steele M; Kim JH; Zolondick AA; Xue J; Xu R; Saito M; Pastorino S; Minaai M; Takanishi Y; Emi M; Pagano I; Wakeham A; Berger T; Pass HI; Gaudino G; Mak TW; Carbone M; Yang H Proc Natl Acad Sci U S A; 2023 Sep; 120(39):e2307999120. PubMed ID: 37729199 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]